These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 23400394

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
    Purandare NC, Pramesh CS, Agarwal JP, Agrawal A, Shah S, Prabhash K, Karimundackal G, Jiwnani S, Tandon S, Rangarajan V.
    Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
    [Abstract] [Full Text] [Related]

  • 5. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
    Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L, Alavi A.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
    [Abstract] [Full Text] [Related]

  • 6. Solid splenic masses: evaluation with 18F-FDG PET/CT.
    Metser U, Miller E, Kessler A, Lerman H, Lievshitz G, Oren R, Even-Sapir E.
    J Nucl Med; 2005 Jan; 46(1):52-9. PubMed ID: 15632034
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.
    Sim YT, Goh YG, Dempsey MF, Han S, Poon FW.
    Lung; 2013 Dec; 191(6):625-32. PubMed ID: 24013495
    [Abstract] [Full Text] [Related]

  • 9. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
    Kim SC, Machac J, Krynyckyi BR, Knesaurek K, Krellenstein D, Schultz B, Gribetz A, DePalo L, Teirstein A, Kim CK.
    Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
    [Abstract] [Full Text] [Related]

  • 10. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2007 May; 83(5):1826-9; discussion 1829-30. PubMed ID: 17462407
    [Abstract] [Full Text] [Related]

  • 11. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P, Musto A, Orazi L, Zamagni C, Rosati M, Allegri V, Cacciari N, Al-Nahhas A, Rubello D, Venturoli S, Fanti S.
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases.
    Huang YE, Huang YJ, Ko M, Hsu CC, Chen CF.
    Ann Nucl Med; 2016 Nov; 30(9):652-658. PubMed ID: 27492555
    [Abstract] [Full Text] [Related]

  • 14. Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.
    Parghane RV, Basu S.
    Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
    [Abstract] [Full Text] [Related]

  • 15. Malignant disease as an incidental finding at ¹⁸F-FDG-PET/CT scanning in patients with granulomatous lung disease.
    Huber H, Hodolic M, Stelzmüller I, Wunn R, Hatzl M, Fellner F, Lamprecht B, Rubello D, Colletti PM, Gabriel M.
    Nucl Med Commun; 2015 May; 36(5):430-7. PubMed ID: 25646704
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer patients.
    Lu Y, Xie D, Huang W, Gong H, Yu J.
    Neoplasma; 2010 May; 57(2):129-34. PubMed ID: 20099976
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.